Jul 25, 2024, 12:00 AM
Jul 25, 2024, 12:00 AM

Ford and Molina Healthcare Report Mixed Earnings Amid Market Reactions

Highlights
  • Ford Motor Company, Viking Therapeutics, and ServiceNow are experiencing significant midday stock movements.
  • Ford's stock is particularly notable, reflecting a mix of positive and negative sentiment among investors.
  • Viking Therapeutics and ServiceNow are also trending, indicating active trading interest in these companies.
Story

Ford Motor Company reported adjusted earnings per share of 47 cents for the second quarter, falling short of the consensus forecast of 68 cents, according to LSEG. Despite this, the automaker's revenue of $44.81 billion exceeded expectations of $44.02 billion. In contrast, Molina Healthcare saw its shares surge over 12% after reaffirming its full-year guidance for adjusted earnings of at least $23.50 per share, alongside second-quarter results that surpassed earnings and revenue expectations. In other earnings news, Edwards Lifesciences reported adjusted earnings of 70 cents per share, slightly above the anticipated 69 cents. American Airlines also exceeded expectations with adjusted earnings of $1.09 per share, surpassing the $1.05 forecast. RTX, formerly Raytheon Technologies, posted earnings of $1.41 per share, beating the analysts' estimate of $1.30. International Business Machines (IBM) saw its stock rise more than 4% after reporting second-quarter earnings of $2.20 per share on revenue of $15.62 billion, both figures surpassing analyst expectations. Northrop Grumman's shares climbed over 6% following its earnings report, which beat expectations of $5.93 per share on $10.02 billion in revenue, prompting the company to raise its full-year forecast. Conversely, Align Technology experienced a decline of more than 7% in its shares after disappointing forecasts and slightly lower-than-expected revenue. The company reported adjusted earnings of $2.41 per share, just shy of the $2.30 estimate, reflecting challenges in the market.

Opinions

You've reached the end